General Precision Point Diagnostics February 5, 2024

Type 2 Diabetes has long been associated with diet and obesity, but there have been hints for more than a century that it may stem from inflammation. In the later part of the 19th century, as salicylates were more effectively extracted from natural sources like willows, manufacturers were able to create readily usable forms of compounds like aspirin. Natural sources of salicylates had been used for millennia as a way to decrease fever and inflammation, and aspirin was just a more convenient and potent way to administer these compounds. Researchers in the 1870s investigated salicylic acid (aspirin is acetylsalicylic acid ) in the treatment of various diseases, including Type 2 Diabetes (Rena and Sakamoto, 2014). They found that salicylic acid is antihyperglycemic, meaning it helps reduce and control blood sugar. This research largely lay dormant until the 1950s, when further research also showed both its effects on hyperglycemia and demonstrated how it was an inflammation mediator. Again, the dots weren’t connected until quite recently: “Over a hundred years ago, high doses of salicylates were shown to lower glucose levels in diabetic patients. This should have been an important clue to link inflammation to the pathogenesis of type 2 diabetes (T2D), but the antihyperglycemic and antiinflammatory effects of salicylates were not connected to the pathogenesis of insulin resistance until recently.” (Shoelson, et al, 2006)

Now that researchers and clinicians had made the connection between inflammation and Type 2 Diabetes, the next step was to focus further research on ways to determine what sort of bodily inflammation caused Type 2 Diabetes, and how to treat it by reducing that inflammation. “The evolving concept of insulin resistance and T2D as having immunological components and an improving picture of how inflammation modulates metabolism provides new opportunities for using antiinflammatory strategies to correct the metabolic consequences of excess adiposity.” (Shoelson, et al, 2006, cited above). The “excess adiposity” referred to here is obesity- having too much adipose tissue in the body. In other words, excess weight combined with inflammation causes the metabolic effect of Type 2 Diabetes. Losing weight and controlling your diet, along with exercise has long been seen as the way to prevent, and even reverse diabetes. Not everyone is successful in this, and given the toll that diabetes takes on the body (including death), ways to remedy inflammation should also be found. How? Inflammation where?

The gut, and more specifically the microbiome has recently been identified as one of the keys to the inflammation associated with Diabetes: 

“In the past few years, a two-way relationship between the gut microbiome in the host’s energy balance and immune function has been demonstrated. The gut microbiome seems to differ between obese and lean subjects, flora composition influences metabolism, and inversely, diet and metabolic status influence the composition of the gut flora, while a fecal microbiome transplantation from lean donors to insulin-resistant subjects results in beneficial metabolic effects. It has been postulated that products from the gut microbiome may interact with the immune system inducing a tissue metabolic modification, which feeds the molecular origin of the low-grade inflammation that characterizes the onset of obesity and diabetes.” (Tsalamandris, et al, 2019). So, obese people have an altered microbiome, and that altered microbiome means that inflammation occurs in the gut, which drives the onset of diabetes. In fact, intervening in gut inflammation could very well be a way to also intervene in diabetes and prevent or perhaps even reverse the condition:

“an alteration in the microbiota to host immune system balance leads to an increased translocation of bacterial antigens towards metabolically active tissues and could result in a chronic inflammatory state and consequently impaired metabolic functions such as insulin resistance, hepatic fat deposition, insulin unresponsiveness, and excessive adipose tissue development. This imbalance could be at the onset of metabolic disease, and therefore the early treatment of the microbiota dysbiosis or immunomodulatory strategies should prevent and slow down the epidemic of metabolic diseases and hence the corresponding lethal cardiovascular consequences.” (Burcelin, et al, 2012). So, the argument is that an altered microbiome could result in chronic inflammation, more weight gain (specifically from fat deposits), insulin resistance, and therefore metabolic disease (diabetes). Treatment of gut dysbiosis should be an early and ongoing intervention.

Aside from losing weight, and altering your diet, one of the most effective treatments may be to treat your microbiome. There are a number of ways that your microbiome can be disturbed- antibiotics, too little fiber in the diet, food allergies, and too much processed food and sugars. All of these things can alter the composition of the bacteria that make up your gut microbiome. Conversely, fiber has been demonstrated to have a beneficial effect on gut flora, and also to decrease the uptake of glucose. Eating a better diet can start with fiber, and fresh vegetables and fruit. Limiting sugar and carbohydrates is key, and adding in some compounds that limit glucose levels in the blood can help. For general gut health, particularly of the microbiome, a good quality probiotic can enhance the variety and quality of gut flora. Antioxidants can act to decrease inflammation. 

So what impact should this knowledge have on the early surveillance of diabetes risk in a patient? Aside from the various tests that assess glucose, these studies suggest that detection of a disturbed microbiome in a patient, particularly one who is obese, may indicate the early stages of a progression toward diabetes, and further suggest that interventions to correct gut dysbiosis may prevent or delay diabetic onset. Similarly, an assessment of oxidative stress, particularly when combined with gut dysbiosis in overweight or obese patients can allow early intervention to combat the inflammation which can be a root cause of diabetes. One of our comprehensive stool and gut assessments combined with our Advanced Oxidative Stress Test could be an excellent way to do any early assessment for diabetic risk when glucose disturbance may not have occurred yet, particularly for overweight patients.

You Might Also Like

General • Precision Point Diagnostics • February 27, 2024

A Functional Approach to Adrenal Stress

Read More
General • Precision Point Diagnostics • February 27, 2024

Why Test Vitamin D?

Read More
General • Precision Point Diagnostics • February 1, 2024

Antioxidant Strategy

Read More